Back to
WELLS FARGO & COMPANY/MN
FUSN7 quarters
Position history for
WELLS FARGO & COMPANY/MN's holdings in FUSION PHARMACEUTICALS INC
As of its Q1 2024 13F, Wells Fargo held 1,500 shares of FUSN (Fusion Pharmaceuticals), worth $31,980. Wells Fargo's 13F filings listed FUSN from Q4 2023 to Q1 2024, 2 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$271,000
Total Shares Change
-15,517
Quarter-by-Quarter History
Other major holders of FUSN: FEDERATED HERMES, INC., FIL Ltd, Pentwater Capital Management LP, CANADA PENSION PLAN INVESTMENT BOARD